Q
Qixue Wang
Researcher at Tianjin Medical University General Hospital
Publications - 74
Citations - 2824
Qixue Wang is an academic researcher from Tianjin Medical University General Hospital. The author has contributed to research in topics: Medicine & Glioma. The author has an hindex of 22, co-authored 51 publications receiving 1745 citations. Previous affiliations of Qixue Wang include Chinese Ministry of Education.
Papers
More filters
Journal ArticleDOI
CGCG clinical practice guidelines for the management of adult diffuse gliomas
Tao Jiang,Do-Hyun Nam,Zvi Ram,Wai Sang Poon,Jiguang Wang,Damdindorj Boldbaatar,Ying Mao,Wenbin Ma,Qing Mao,Yongping You,Chuanlu Jiang,Xuejun Yang,Chunsheng Kang,Xiaoguang Qiu,Wenbin Li,Shaowu Li,Ling Chen,Xuejun Li,Zhixiong Liu,Weimin Wang,Hongmin Bai,Yu Yao,Shouwei Li,Anhua Wu,Ke Sai,Guilin Li,Kun Yao,Xinting Wei,Xianzhi Liu,Zhiwen Zhang,Yiwu Dai,Sheng-Qing Lv,Liang Wang,Zhixiong Lin,Jun Dong,Guozheng Xu,Xiaodong Ma,Wei Zhang,Chuanbao Zhang,Baoshi Chen,Gan You,Yongzhi Wang,Yinyan Wang,Zhaoshi Bao,Pei Yang,Xing Fan,Xing Liu,Zheng Zhao,Zheng Wang,Yiming Li,Zhiliang Wang,Guanzhang Li,Shengyu Fang,Lianwang Li,Yanwei Liu,Shuai Liu,Xia Shan,Yu-Qing Liu,Ruichao Chai,Huimin Hu,Jing Chen,Wei Yan,Jinquan Cai,Hongjun Wang,Lingchao Chen,Yuan Yang,Yu Wang,Lei Han,Qixue Wang +68 more
TL;DR: The recommendations will provide a framework and assurance for the strategy of diagnostic and therapeutic measures to reduce complications from unnecessary treatment and cost and should serve as an application for all professionals involved in the management of patients with adult diffuse glioma and also as a source of knowledge for insurance companies and other institutionsinvolved in the cost regulation of cancer care in China.
Journal ArticleDOI
Long Noncoding RNA NEAT1, Regulated by the EGFR Pathway, Contributes to Glioblastoma Progression Through the WNT/β-Catenin Pathway by Scaffolding EZH2.
Qun Chen,Qun Chen,Jinquan Cai,Jinquan Cai,Qixue Wang,Yunfei Wang,Mingyang Liu,Jingxuan Yang,Junhu Zhou,Chunsheng Kang,Min Li,Chuanlu Jiang,Chuanlu Jiang +12 more
TL;DR: The EGFR/NEAT1/EZH2/β-catenin axis serves as a critical effector of tumorigenesis and progression, suggesting new therapeutic directions in glioblastoma.
Journal ArticleDOI
Long non-coding RNA HOTAIR promotes glioblastoma cell cycle progression in an EZH2 dependent manner.
Kailiang Zhang,Xiaotian Sun,Xuan Zhou,Lei Han,Luyue Chen,Zhendong Shi,Anling Zhang,Minhua Ye,Qixue Wang,Chaoyong Liu,Jianwei Wei,Yu Ren,Jingxuan Yang,Jianning Zhang,Peiyu Pu,Min Li,Chunsheng Kang +16 more
TL;DR: It is found that EZH2 (predominant PRC2 complex component) inhibition blocked cell cycle progression in glioma cells, consistent with the effects elicited by HOTAIR siRNA.
Journal ArticleDOI
A novel cell cycle-associated lncRNA, HOXA11-AS, is transcribed from the 5-prime end of the HOXA transcript and is a biomarker of progression in glioma.
Qixue Wang,Junxia Zhang,Yanwei Liu,Wei Zhang,Junhu Zhou,Ran Duan,Peiyu Pu,Chunsheng Kang,Lei Han +8 more
TL;DR: It is confirmed, for the first time, that HOXA11-AS is an important long non-coding RNA that primarily serves as a prognostic factor for glioma patient survival.
Journal ArticleDOI
m6A RNA methylation regulators contribute to malignant progression and have clinical prognostic impact in gliomas.
Rui-Chao Chai,Fan Wu,Qixue Wang,Shu Zhang,Kenan Zhang,Yu-Qing Liu,Zheng Zhao,Tao Jiang,Yong-Zhi Wang,Chunsheng Kang,Chunsheng Kang +10 more
TL;DR: It is demonstrated that most of the thirteen main m6A RNA methylation regulators are differentially expressed among gliomas stratified by different clinicopathological features in 904gliomas, and derived a risk signature that is not only an independent prognostic marker but can also predict the clinicopathic features of glioma malignancy.